Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
Claverie R, Perriguey M, Rico A, Boutiere C, Demortiere S, Durozard P, Hilezian F, Dubrou C, Vely F, Pelletier J, Audoin B, Maarouf A.
Claverie R, et al. Among authors: perriguey m.
Neurol Neuroimmunol Neuroinflamm. 2023 Aug 21;10(5):e200152. doi: 10.1212/NXI.0000000000200152. Print 2023 Sep.
Neurol Neuroimmunol Neuroinflamm. 2023.
PMID: 37604695
Free PMC article.